Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Ferguson
FERG
|
$740M |
| 2 |
Uber
UBER
|
$498M |
| 3 |
DexCom
DXCM
|
$449M |
| 4 |
Meta Platforms (Facebook)
META
|
$312M |
| 5 |
Autodesk
ADSK
|
$305M |
Top Sells
| 1 |
Salesforce
CRM
|
$1.28B |
| 2 |
Apple
AAPL
|
$916M |
| 3 |
PayPal
PYPL
|
$610M |
| 4 |
Bristol-Myers Squibb
BMY
|
$477M |
| 5 |
Accenture
ACN
|
$391M |
Sector Composition
| 1 | Technology | 30.51% |
| 2 | Healthcare | 19.12% |
| 3 | Consumer Discretionary | 11.48% |
| 4 | Financials | 10.31% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
IBM
IBM
$227B
| $400M | 0.18% | 3,004,120 +90,976 | +3% | +$12.1M |
|
127
RingCentral
RNG
$2.76B
| $398M | 0.18% | 1,335,150 +122,424 | +10% | +$36.5M |
|
128
Globus Medical
GMED
$8.27B
| $396M | 0.18% | 6,422,806 -18,953 | -0.3% | -$1.17M |
|
129
Burlington
BURL
$18.3B
| $392M | 0.18% | 1,310,700 -20,308 | -2% | -$6.07M |
|
130
Novartis
NVS
$245B
| $392M | 0.18% | 4,581,365 -88,236 | -2% | -$7.54M |
|
131
Estee Lauder
EL
$33B
| $391M | 0.18% | 1,344,363 +222,681 | +20% | +$64.8M |
|
132
BioMarin Pharmaceuticals
BMRN
$11.2B
| $377M | 0.17% | 4,993,655 -693,287 | -12% | -$52.4M |
|
133
Stryker
SYK
$150B
| $376M | 0.17% | 1,542,211 +225,554 | +17% | +$54.9M |
|
134
Fastenal
FAST
$57B
| $375M | 0.17% | 7,464,057 +403,177 | +6% | +$20.3M |
|
135
Dynatrace
DT
$15.3B
| $373M | 0.17% | 7,739,260 +713,095 | +10% | +$34.4M |
|
136
Ziff Davis
ZD
$1.57B
| $372M | 0.17% | 3,107,080 +1,140,230 | +58% | +$137M |
|
137
General Dynamics
GD
$87.3B
| $372M | 0.17% | 2,046,907 -253,558 | -11% | -$46M |
|
138
NXP Semiconductors
NXPI
$59.2B
| $369M | 0.17% | 1,832,204 +655,524 | +56% | +$132M |
|
139
RB Global
RBA
$21.3B
| $368M | 0.17% | 6,290,130 +32,205 | +0.5% | +$1.89M |
|
140
Aramark
ARMK
$10.3B
| $368M | 0.17% | 9,746,302 +41,919 | +0.4% | +$1.58M |
|
|
PRAH
141
DELISTED
PRA Health Sciences, Inc.
PRAH
| $368M | 0.17% | 2,398,640 -3,271 | -0.1% | -$502K |
|
142
Hilton Worldwide
HLT
$64.9B
| $365M | 0.17% | 3,019,482 +260,303 | +9% | +$31.5M |
|
143
Constellation Brands
STZ
$28.5B
| $364M | 0.17% | 1,597,736 -59,952 | -4% | -$13.7M |
|
144
Advanced Micro Devices
AMD
$264B
| $364M | 0.17% | 4,635,633 +840,677 | +22% | +$66M |
|
|
145
PayPal
PYPL
$67.1B
| $362M | 0.17% | 1,492,291 -2,513,133 | -63% | -$610M |
|
146
Citigroup
C
$178B
| $362M | 0.17% | 4,977,477 -129,942 | -3% | -$9.45M |
|
147
Motorola Solutions
MSI
$78.7B
| $361M | 0.16% | 1,920,028 +365,824 | +24% | +$68.8M |
|
148
IQVIA
IQV
$32.4B
| $361M | 0.16% | 1,868,392 -226,344 | -11% | -$43.7M |
|
149
CVS Health
CVS
$92.8B
| $357M | 0.16% | 4,752,093 +1,124,402 | +31% | +$84.6M |
|
150
Johnson & Johnson
JNJ
$427B
| $357M | 0.16% | 2,174,037 -387,016 | -15% | -$63.6M |
|